324 related articles for article (PubMed ID: 29084123)
1. A Survey of Prescribers' Attitudes, Knowledge, Comfort, and Fear of Consequences Related to an Opioid Overdose Education and Naloxone Distribution Program.
Peckham AM; Niculete ME; Steinberg H; Boggs DL
J Public Health Manag Pract; 2018; 24(4):310-317. PubMed ID: 29084123
[TBL] [Abstract][Full Text] [Related]
2. Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings.
Winograd RP; Davis CS; Niculete M; Oliva E; Martielli RP
Subst Abus; 2017; 38(2):135-140. PubMed ID: 28486076
[TBL] [Abstract][Full Text] [Related]
3. Implementation and evaluation of an opioid overdose education and naloxone distribution (OEND) program at a Veterans Affairs Medical Center.
Pauly JB; Vartan CM; Brooks AT
Subst Abus; 2018; 39(2):206-210. PubMed ID: 29565760
[TBL] [Abstract][Full Text] [Related]
4. Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration.
Bounthavong M; Devine EB; Christopher MLD; Harvey MA; Veenstra DL; Basu A
Health Serv Res; 2019 Oct; 54(5):1055-1064. PubMed ID: 31313839
[TBL] [Abstract][Full Text] [Related]
5. Telephone-based opioid overdose education and naloxone distribution (OEND) pharmacy consult clinic.
Szydlowski EM; Caruana SS
Subst Abus; 2018; 39(2):145-151. PubMed ID: 31032747
[TBL] [Abstract][Full Text] [Related]
6. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.
Oliva EM; Christopher MLD; Wells D; Bounthavong M; Harvey M; Himstreet J; Emmendorfer T; Valentino M; Franchi M; Goodman F; Trafton JA;
J Am Pharm Assoc (2003); 2017; 57(2S):S168-S179.e4. PubMed ID: 28292502
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacist involvement in expanding naloxone distribution in a veteran population.
McQuillan A
Am J Health Syst Pharm; 2022 Mar; 79(6):472-476. PubMed ID: 34755851
[TBL] [Abstract][Full Text] [Related]
8. Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs.
Oliva EM; Nevedal A; Lewis ET; McCaa MD; Cochran MF; Konicki PE; Davis CS; Wilder C
Subst Abus; 2016; 37(1):118-26. PubMed ID: 26675643
[TBL] [Abstract][Full Text] [Related]
9. Overdose Education and Naloxone Distribution Program Attendees: Who Attends, What Do They Know, and How Do They Feel?
Heavey SC; Burstein G; Moore C; Homish GG
J Public Health Manag Pract; 2018; 24(1):63-68. PubMed ID: 28257406
[TBL] [Abstract][Full Text] [Related]
10. Physician and Pharmacist: Attitudes, Facilitators, and Barriers to Prescribing Naloxone for Home Rescue.
Martino JG; Smith SR; Rafie S; Rafie S; Marienfeld C
Am J Addict; 2020 Jan; 29(1):65-72. PubMed ID: 31804746
[TBL] [Abstract][Full Text] [Related]
11. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
Kohan LR; Elmofty D; Pena I; Liao C
J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
[TBL] [Abstract][Full Text] [Related]
12. Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary analysis.
Bounthavong M; Harvey MA; Wells DL; Popish SJ; Himstreet J; Oliva EM; Kay CL; Lau MK; Randeria-Noor PP; Phillips AG; Christopher MLD
J Am Pharm Assoc (2003); 2017; 57(2S):S68-S72. PubMed ID: 28089521
[TBL] [Abstract][Full Text] [Related]
13. Assessment of a naloxone distribution plan in a veteran population who experienced an opioid-related overdose event.
Alexander M; Hooker J; Stratton M; Huh M; Houck K
J Am Pharm Assoc (2003); 2024; 64(3):101999. PubMed ID: 38151200
[TBL] [Abstract][Full Text] [Related]
14. Naloxone Counseling for Harm Reduction and Patient Engagement.
Han JK; Hill LG; Koenig ME; Das N
Fam Med; 2017 Oct; 49(9):730-733. PubMed ID: 29045991
[TBL] [Abstract][Full Text] [Related]
15. Exploring Providers' Perception to Naloxone Education for Opioid Overdose After Receiving Academic Detailing at the U.S. Department of Veterans Affairs.
Bounthavong M; Christopher MLD; Veenstra DL; Basu A; Devine EB
J Pharm Pract; 2023 Jun; 36(3):514-522. PubMed ID: 34766510
[No Abstract] [Full Text] [Related]
16. Implementing an overdose education and naloxone distribution program in a health system.
Devries J; Rafie S; Polston G
J Am Pharm Assoc (2003); 2017; 57(2S):S154-S160. PubMed ID: 28233681
[TBL] [Abstract][Full Text] [Related]
17. Survey of Primary Care and Mental Health Prescribers' Perspectives on Reducing Opioid and Benzodiazepine Co-Prescribing Among Veterans.
Hawkins EJ; Malte CA; Hagedorn HJ; Berger D; Frank A; Lott A; Achtmeyer CE; Mariano AJ; Saxon AJ
Pain Med; 2017 Mar; 18(3):454-467. PubMed ID: 27558857
[TBL] [Abstract][Full Text] [Related]
18. Emergency physicians' attitudes and perceived barriers to the implementation of take-home naloxone programs in Canadian emergency departments.
Lacroix L; Thurgur L; Orkin AM; Perry JJ; Stiell IG
CJEM; 2018 Jan; 20(1):46-52. PubMed ID: 28918769
[TBL] [Abstract][Full Text] [Related]
19. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
Lambdin BH; Davis CS; Wheeler E; Tueller S; Kral AH
Drug Alcohol Depend; 2018 Jul; 188():370-376. PubMed ID: 29776688
[TBL] [Abstract][Full Text] [Related]
20. Barriers to Utilization of Prescription Drug Monitoring Programs Among Prescribing Physicians and Advanced Practice Registered Nurses at Veterans Health Administration Facilities in Oregon.
Mastarone GL; Wyse JJ; Wilbur ER; Morasco BJ; Saha S; Carlson KF
Pain Med; 2020 Apr; 21(4):695-703. PubMed ID: 31722393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
